002821 凯莱英
交易中 06-18 11:08:24
资讯
新帖
简况
凯莱英（002821）披露调整2025年A股限制性股票激励计划相关事项的公告，6月17日股价上涨2.61%
证券之星 · 06-17 22:35
凯莱英（002821）披露调整2025年A股限制性股票激励计划相关事项的公告，6月17日股价上涨2.61%
凯莱英(06821)：购回及注销共计11.75万股限制性A股股份
智通财经 · 06-17 21:53
凯莱英(06821)：购回及注销共计11.75万股限制性A股股份
凯莱英：每10股派13.00元，股权登记日为6月25日
南方财经网 · 06-17 19:01
凯莱英：每10股派13.00元，股权登记日为6月25日
凯莱英(06821)：完成购回及注销根据2025年A股计划授出的部分限制性A股股份
智通财经 · 06-12
凯莱英(06821)：完成购回及注销根据2025年A股计划授出的部分限制性A股股份
凯莱英(06821)将于7月24日派发末期股息每10股13元
智通财经 · 06-10
凯莱英(06821)将于7月24日派发末期股息每10股13元
股市必读：凯莱英（002821）6月1日董秘有最新回复
证券之星 · 06-02
股市必读：凯莱英（002821）6月1日董秘有最新回复
富国基金管理有限公司增持凯莱英(06821)5.33万股 每股作价约98.28港元
智通财经 · 05-28
富国基金管理有限公司增持凯莱英(06821)5.33万股 每股作价约98.28港元
小摩减持凯莱英(06821)6.77万股 每股作价约98.5港元
智通财经 · 05-27
小摩减持凯莱英(06821)6.77万股 每股作价约98.5港元
港股异动 | 凯莱英(06821)涨超7% 新兴业务表现强劲 机构看好其长期高增长确定性
智通财经 · 05-21
港股异动 | 凯莱英(06821)涨超7% 新兴业务表现强劲 机构看好其长期高增长确定性
花旗集团在凯莱英H股的多头头寸于5月14日降至4.99%，此前为5.66%
美股速递 · 05-20
花旗集团在凯莱英H股的多头头寸于5月14日降至4.99%，此前为5.66%
凯莱英（002821）披露召开2025年度股东会及系列类别股东会通知，5月15日股价下跌3.45%
证券之星 · 05-15
凯莱英（002821）披露召开2025年度股东会及系列类别股东会通知，5月15日股价下跌3.45%
凯莱英(06821)将于7月24日派发末期股息每10股13元
智通财经 · 05-15
凯莱英(06821)将于7月24日派发末期股息每10股13元
花旗集团于凯莱英H股持股比例自5.91%降至5.36%
美股速递 · 05-13
花旗集团于凯莱英H股持股比例自5.91%降至5.36%
5月11日凯莱英涨5.26%，中欧医疗健康混合A基金重仓该股
证券之星 · 05-11
5月11日凯莱英涨5.26%，中欧医疗健康混合A基金重仓该股
凯莱英涨5.26%，开源证券一个月前给出“买入”评级
证券之星 · 05-11
凯莱英涨5.26%，开源证券一个月前给出“买入”评级
凯莱英（002821）披露H股证券变动月报表，5月6日股价下跌0.7%
证券之星 · 05-06
凯莱英（002821）披露H股证券变动月报表，5月6日股价下跌0.7%
凯莱英：公司持续提升连续性反应以及各项新技术的应用率
证券之星 · 05-06
凯莱英：公司持续提升连续性反应以及各项新技术的应用率
花旗集团在凯莱英H股长仓比重降至7.11% 较4月28日9.86%显著收缩
美股速递 · 05-05
花旗集团在凯莱英H股长仓比重降至7.11% 较4月28日9.86%显著收缩
摩根大通持仓凯莱英H股比例降至7.64% 较上月减持0.54个百分点
美股速递 · 05-04
摩根大通持仓凯莱英H股比例降至7.64% 较上月减持0.54个百分点
每周股票复盘：凯莱英（002821）Q1营收增16.91%至18.02亿元
证券之星 · 05-03
每周股票复盘：凯莱英（002821）Q1营收增16.91%至18.02亿元
加载更多
公司概况
公司名称：
凯莱英医药集团(天津)股份有限公司
所属行业：
医药制造业
上市日期：
2016-11-18
主营业务：
凯莱英医药集团(天津)股份有限公司的主营业务是为国内外制药公司、生物技术公司提供药品全生命周期的一站式服务。公司的主要产品是小分子CDMO解决方案、新兴业务。凯莱英生物AsymBio偶联药物开发平台成功入围第12届WorldADCAwards“BestADCPlatformTechnology”奖项，印证了凯莱英生物在全球抗体偶联药物CDMO领域的卓越地位。
发行价格：
30.53
{"stockData":{"symbol":"002821","market":"SZ","secType":"STK","nameCN":"凯莱英","latestPrice":123.16,"timestamp":1781752104000,"preClose":115,"halted":0,"volume":4014990,"delay":0,"changeRate":0.071,"floatShares":317000000,"shares":361000000,"eps":3.0775,"marketStatus":"交易中","change":8.16,"latestTime":"06-18 11:08:24","open":114.8,"high":124.12,"low":113.6,"amount":478000000,"amplitude":0.0915,"askPrice":123.16,"askSize":2,"bidPrice":123.02,"bidSize":1,"shortable":0,"etf":0,"ttmEps":3.0775,"tradingStatus":2,"nextMarketStatus":{"tag":"午间休市","tradingStatus":4,"beginTime":1781753400000},"marketStatusCode":2,"adr":0,"adjPreClose":115,"symbolType":"stock","openAndCloseTimeList":[[1781746200000,1781753400000],[1781758800000,1781766000000]],"highLimit":126.5,"lowLimit":103.5,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":360780970,"isCdr":false,"pbRate":2.31,"roa":"--","peRate":40.019496,"roe":"1.71%","epsLYR":3.16,"committee":0.298246,"marketValue":44434000000,"turnoverRate":0.0127,"status":0,"hkstockBrief":{"symbol":"06821","market":"HK","secType":"STK","nameCN":"凯莱英","latestPrice":92.35,"timestamp":1781752102760,"preClose":88.85,"halted":0,"volume":184600,"delay":0,"premium":"-35.27"},"floatMarketCap":39047000000},"requestUrl":"/m/hq/s/002821","defaultTab":"news","newsList":[{"id":"2644742397","title":"凯莱英（002821）披露调整2025年A股限制性股票激励计划相关事项的公告，6月17日股价上涨2.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=2644742397","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2644742397?lang=zh_cn&edition=full","pubTime":"2026-06-17 22:35","pubTimestamp":1781706917,"startTime":"0","endTime":"0","summary":"截至2026年6月17日收盘，凯莱英报收于115.0元，较前一交易日上涨2.61%，最新总市值为414.9亿元。该股当日开盘112.08元，最高115.57元，最低111.18元，成交额达3.84亿元，换手率为1.06%。近日，凯莱英医药集团于2026年6月17日召开第五届董事会第十次会议，审议通过《关于调整2025年A股限制性股票激励计划相关事项的议案》。本次调整无需提交股东大会审议，董事会薪酬与考核委员会及律师事务所均发表同意意见。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061700042344.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0132","BK1191","002821","159982","06821","LU1328615791.USD","BK0239","399300"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644374121","title":"凯莱英(06821)：购回及注销共计11.75万股限制性A股股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2644374121","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2644374121?lang=zh_cn&edition=full","pubTime":"2026-06-17 21:53","pubTimestamp":1781704439,"startTime":"0","endTime":"0","summary":"智通财经APP讯，凯莱英(06821)发布公告，于2026年6月17日，公司董事会审议并通过了“关于回购注销2025年A股计划部分限制性股票的议案”，据此将购回及注销共计11.75万股由11名已辞职激励对象根据2025年A股计划首次授予，及四名已辞职激励对象根据2025年A股计划预留授予所持有的已授出但尚未解禁的限制性A股股份。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1455815.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0132","002821","399300","BK0239","LU1328615791.USD","BK1191","06821","159982"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644748042","title":"凯莱英：每10股派13.00元，股权登记日为6月25日","url":"https://stock-news.laohu8.com/highlight/detail?id=2644748042","media":"南方财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2644748042?lang=zh_cn&edition=full","pubTime":"2026-06-17 19:01","pubTimestamp":1781694060,"startTime":"0","endTime":"0","summary":"南财智讯6月17日电，凯莱英发布2025年年度权益分派实施公告，以公司现有A股总股本剔除已回购股份后的股本为基数，向全体A股股东每10股派13.00元人民币现金（含税），股权登记日为6月25日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202606173774737246.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["06821","BK0132","BK0239","BK1191","LU1328615791.USD","002821"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642226709","title":"凯莱英(06821)：完成购回及注销根据2025年A股计划授出的部分限制性A股股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2642226709","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642226709?lang=zh_cn&edition=full","pubTime":"2026-06-12 19:25","pubTimestamp":1781263518,"startTime":"0","endTime":"0","summary":"智通财经APP讯，凯莱英(06821)发布公告，有关(其中包括)购回及注销根据2025年A股计划授出的部分限制性A股股份。截至本公告日期，已完成购回及注销(i)11名已离职激励对象所持有的根据2025年A股计划首次授予的及(ii)2名已离职激励对象所持有的根据2025年A股计划预留授予的合计共9.4万股限制性A股股份。公司已发行股本已由360,874,970股股份(包括333,040,460股A股及27,834,510股H股)减少至360,780,970股股份(包括332,946,460股A股及27,834,510股H股)。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1453879.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["399300","BK0239","LU1328615791.USD","002821","06821","BK1191","BK0132","159982"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642421265","title":"凯莱英(06821)将于7月24日派发末期股息每10股13元","url":"https://stock-news.laohu8.com/highlight/detail?id=2642421265","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642421265?lang=zh_cn&edition=full","pubTime":"2026-06-10 21:58","pubTimestamp":1781099912,"startTime":"0","endTime":"0","summary":"智通财经APP讯，凯莱英(06821)发布公告，该公司将于2026年7月24日派发末期股息每10股13元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1452844.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4588","BK0132","06821","002821","BK0239","BK1191","VIG","LU1328615791.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640966109","title":"股市必读：凯莱英（002821）6月1日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2640966109","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640966109?lang=zh_cn&edition=full","pubTime":"2026-06-02 01:43","pubTimestamp":1780335787,"startTime":"0","endTime":"0","summary":"截至2026年6月1日收盘，凯莱英报收于115.39元，下跌1.73%，换手率2.47%，成交量7.82万手，成交额9.32亿元。董秘最新回复投资者： 你好，公司最新股东户数是多少，或者截止5.20收盘后的股东户数是多少？公司在信息披露方面为遵循谨慎公平原则，故不在互动平台上披露股东人数信息。当日关注点来自交易信息汇总：6月1日主力资金净流入834.43万元，显示主力对个股短期态度偏积极。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060200001418.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["06821","BK0239","BK1191","BK0132","002821","LU1328615791.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638769349","title":"富国基金管理有限公司增持凯莱英(06821)5.33万股 每股作价约98.28港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2638769349","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638769349?lang=zh_cn&edition=full","pubTime":"2026-05-28 20:24","pubTimestamp":1779971092,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，香港联交所最新资料显示，5月22日，富国基金管理有限公司增持凯莱英(06821)5.33万股，每股作价98.2793港元，总金额约为523.83万港元。增持后最新持股数目约为141.13万股，最新持股比例为5.07%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1447375.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["EWH","LU1328615791.USD","BK0239","06821","002821","BK1191","BK0132"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638750297","title":"小摩减持凯莱英(06821)6.77万股 每股作价约98.5港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2638750297","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638750297?lang=zh_cn&edition=full","pubTime":"2026-05-27 19:25","pubTimestamp":1779881124,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，香港联交所最新资料显示，5月21日，小摩减持凯莱英(06821)6.77万股，每股作价98.5021港元，总金额约为666.86万港元。减持后最新持股数目约为163.88万股，最新持股比例为5.88%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1446756.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["JPO","LU0203347892.USD","JPMO","BK4588","EWH","06821","LU1629891620.HKD","LU2211815571.USD","BK0239","IE00BBT3K403.USD","IE00BFXG1179.USD","LU0203345920.USD","LU1032466523.USD","LU2746668974.SGD","IE000M9KFDE8.USD","LU0048584097.USD","IE00BYXW3230.USD","LU2237443895.HKD","LU1914381329.SGD","LU2552382215.SGD","LU2756315318.SGD","IE00BHPRN162.USD","LU0689472784.USD","IE00BLSP4239.USD","BK4550","LU0943347566.SGD","LU0211328371.USD","LU0070302665.USD","002821","LU0417517546.SGD","LU1496350171.SGD","LU1145028129.USD","LU1162221912.USD","LU0211326755.USD","IE00BJTD4V19.USD","LU1670628061.USD","LU2237443622.USD","IE00BJTD4N35.SGD","LU0211326839.USD","SG9999002232.USD","BK4207","LU0820561818.USD","LU0238689110.USD","LU2237443978.SGD","LU1119994496.HKD","LU1267930490.SGD","JPX","LU1720051017.SGD","LU1496350502.SGD","LU2552382058.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637584807","title":"港股异动 | 凯莱英(06821)涨超7% 新兴业务表现强劲 机构看好其长期高增长确定性","url":"https://stock-news.laohu8.com/highlight/detail?id=2637584807","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637584807?lang=zh_cn&edition=full","pubTime":"2026-05-21 14:51","pubTimestamp":1779346283,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，凯莱英涨超7%，截至发稿，涨7.85%，报99.65港元，成交额7212万港元。消息面上， 凯莱英一季度业绩显示，营业收入18.02亿元，同比增16.91%；经调整归母净利润4.23亿元，同比增27.91%。分业务来看，一季度小分子CDMO 业务收入12亿元，同比增长 0.43%，恒定汇率下增长 3.26%；新兴业务收入5.98亿元，同比增长74.07%，主要是化学大分子和生物大分子业务板块增长强劲。公司在高景气度赛道的后期订单规模扩大和前瞻性投入，可望带来较强的长期高增长确定性。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1444417.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","LU1328615791.USD","BK4585","06821","BK0132","BK4588","002821","VXUS","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1113303833","title":"花旗集团在凯莱英H股的多头头寸于5月14日降至4.99%，此前为5.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=1113303833","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1113303833?lang=zh_cn&edition=full","pubTime":"2026-05-20 17:38","pubTimestamp":1779269889,"startTime":"0","endTime":"0","summary":"根据香港交易所披露的数据，花旗集团持有的凯莱英H股多头头寸比例已出现显著变动。\n截至5月14日，该比例从先前的5.66%下降至4.99%。\n这一变动意味着花旗集团在凯莱英H股中的权益占比已低于5%的披露门槛，通常被视为机构投资者持仓调整的重要观察节点。\n市场参与者将密切关注此类持股变动，以分析机构对相关股票未来走势的看法与策略调整。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["002821","BK0239","BK0132","LU1328615791.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635203891","title":"凯莱英（002821）披露召开2025年度股东会及系列类别股东会通知，5月15日股价下跌3.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2635203891","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635203891?lang=zh_cn&edition=full","pubTime":"2026-05-15 22:04","pubTimestamp":1778853891,"startTime":"0","endTime":"0","summary":"截至2026年5月15日收盘，凯莱英报收于117.97元，较前一交易日下跌3.45%，最新总市值为425.72亿元。该股当日开盘122.41元，最高125.31元，最低116.92元，成交额达10.31亿元，换手率为2.7%。近日，凯莱英医药集团（天津）股份有限公司发布《关于召开2025年度股东会、2026年第二次A股类别股东会及2026年第二次H股类别股东会的通知》。股权登记日为2026年6月2日，A股股东可通过深圳证券交易所系统或互联网投票系统参与网络投票。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051500043789.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["06821","BK0132","LU1328615791.USD","BK0239","002821","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635084117","title":"凯莱英(06821)将于7月24日派发末期股息每10股13元","url":"https://stock-news.laohu8.com/highlight/detail?id=2635084117","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635084117?lang=zh_cn&edition=full","pubTime":"2026-05-15 20:20","pubTimestamp":1778847630,"startTime":"0","endTime":"0","summary":"智通财经APP讯，凯莱英(06821)发布公告，该公司将于2026年7月24日派发截至2025年12月31日止年度的末期股息每10股13元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1442453.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["002821","06821","BK0132","LU1328615791.USD","BK1191","BK0239","BK4585","BK4588","VIG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1178542171","title":"花旗集团于凯莱英H股持股比例自5.91%降至5.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=1178542171","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1178542171?lang=zh_cn&edition=full","pubTime":"2026-05-13 18:07","pubTimestamp":1778666870,"startTime":"0","endTime":"0","summary":"根据香港交易所披露的最新权益变动信息，花旗集团在凯莱英H股的持股比例出现下降。具体数据显示，截至5月7日，花旗集团所持好仓头寸占该股已发行H股的比例已从此前的5.91%降至5.36%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["002821","LU1328615791.USD","BK1191","BK0132","BK0239","06821"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634740914","title":"5月11日凯莱英涨5.26%，中欧医疗健康混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2634740914","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634740914?lang=zh_cn&edition=full","pubTime":"2026-05-11 16:36","pubTimestamp":1778488569,"startTime":"0","endTime":"0","summary":"证券之星消息，5月11日凯莱英涨5.26%，收盘报130.08元，换手率3.46%，成交量10.96万手，成交额13.92亿元。根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共67家，其中持有数量最多的公募基金为中欧基金的中欧医疗健康混合A。中欧医疗健康混合A目前规模为129.74亿元，最新净值1.742，较上一交易日下跌2.72%，近一年上涨10.75%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051100022129.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1328615791.USD","BK0239","159760","06821","002821","BK1191","BK0132"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634409976","title":"凯莱英涨5.26%，开源证券一个月前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2634409976","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634409976?lang=zh_cn&edition=full","pubTime":"2026-05-11 16:35","pubTimestamp":1778488559,"startTime":"0","endTime":"0","summary":"今日凯莱英涨5.26%，收盘报130.08元。2026年4月1日，开源证券研究员余汝意发布了对凯莱英的研报《公司信息更新报告：收入利润高质增长，多赛道景气共振下迈向加速周期》，该研报对凯莱英给出“买入”评级。研报中预计2026-2028年公司归母净利润为15.07/18.59/23.12亿元，EPS为4.18/5.15/6.41元，当前股价对应PE为24.1/19.5/15.7倍，维持“买入”评级。证券之星数据中心计算显示，对该股盈利预测较准的分析师团队为中国银河的宋丽莹、程培。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051100022123.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["06821","002821","161027"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633131181","title":"凯莱英（002821）披露H股证券变动月报表，5月6日股价下跌0.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2633131181","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633131181?lang=zh_cn&edition=full","pubTime":"2026-05-06 22:14","pubTimestamp":1778076864,"startTime":"0","endTime":"0","summary":"截至2026年5月6日收盘，凯莱英报收于124.68元，较前一交易日下跌0.7%，最新总市值为449.94亿元。该股当日开盘123.2元，最高125.48元，最低120.8元，成交额达10.32亿元，换手率为2.63%。近日，凯莱英医药集团（天津）股份有限公司披露《证券变动月报表》。公告显示，截至2026年4月30日，公司H股总数为27,834,510股，全部已发行并上市；A股总数为333,040,460股，其中已发行331,889,160股，库存股1,151,300股。公司确认H股类别已满足联交所规定的公众持股量要求。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050600039681.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["06821","BK1191","BK0239","161027","002821","BK0132","LU1328615791.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633900974","title":"凯莱英：公司持续提升连续性反应以及各项新技术的应用率","url":"https://stock-news.laohu8.com/highlight/detail?id=2633900974","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633900974?lang=zh_cn&edition=full","pubTime":"2026-05-06 16:45","pubTimestamp":1778057123,"startTime":"0","endTime":"0","summary":"证券之星消息，凯莱英05月06日在投资者关系平台上答复投资者关心的问题。基于公平公正的信息披露原则和CDMO行业准则以及商业秘密保护的义务，公司不便回复未曾披露的订单对应主要成分\\主要结构等详细信息。公司持续提升连续性反应以及各项新技术的应用率，在研发投入也保持行业领先。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050600025210.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0132","BK0239","BK1191","LU1328615791.USD","002821","06821"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1160542788","title":"花旗集团在凯莱英H股长仓比重降至7.11% 较4月28日9.86%显著收缩","url":"https://stock-news.laohu8.com/highlight/detail?id=1160542788","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1160542788?lang=zh_cn&edition=full","pubTime":"2026-05-05 17:32","pubTimestamp":1777973540,"startTime":"0","endTime":"0","summary":"香港交易所最新披露数据显示，花旗集团对凯莱英（Asymchem Laboratories）H股的持股权比例出现明显调整。截至4月28日，其长仓持仓比例从先前公布的9.86%下降至7.11%，减持幅度达2.75个百分点。\n此次持股变动引发市场关注，机构投资者对医药外包服务板块的配置策略可能正在发生微妙变化。作为全球领先的医药研发生产服务商，凯莱英的H股流动性向来备受国际资本青睐。花旗集团此次仓位调整是否预示其对CXO行业前景的重新评估，值得进一步观察。\n二级市场数据显示，近期生物医药板块整体面临估值回调压力，机构持仓结构的变化往往成为行业风向标。投资者需密切关注后续可能出现的连锁反应。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0239","BK1191","002821","LU1328615791.USD","06821","BK0132"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1157054122","title":"摩根大通持仓凯莱英H股比例降至7.64% 较上月减持0.54个百分点","url":"https://stock-news.laohu8.com/highlight/detail?id=1157054122","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1157054122?lang=zh_cn&edition=full","pubTime":"2026-05-04 17:27","pubTimestamp":1777886836,"startTime":"0","endTime":"0","summary":"根据香港交易所最新披露文件显示，国际投行摩根大通对凯莱英医药集团H股的持股比例出现调整。截至4月28日，其长期持仓比例已从先前公布的8.18%降至7.64%，减持幅度达0.54个百分点。\n此次持股变动引发市场对机构投资者策略的关注。作为全球领先的医药研发生产服务商，凯莱英近年来持续获得资本市场的青睐。摩根大通此次持仓调整或反映其对该股估值水平的重新评估，亦可能基于投资组合再平衡的常规操作。\n值得关注的是，此次披露的持股比例变化仅涉及H股部分。根据公开信息，凯莱英同时在内地A股市场上市，两地股价走势及机构持仓策略往往存在联动效应。投资者需综合考量企业基本面、行业政策环境及市场流动性等多重因素。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0239","002821","LU1328615791.USD","BK1191","06821","BK0132"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632267153","title":"每周股票复盘：凯莱英（002821）Q1营收增16.91%至18.02亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2632267153","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632267153?lang=zh_cn&edition=full","pubTime":"2026-05-03 01:37","pubTimestamp":1777743429,"startTime":"0","endTime":"0","summary":"截至2026年4月30日收盘，凯莱英报收于125.56元，较上周的117.08元上涨7.24%。本周，凯莱英4月28日盘中最高价报129.49元。本周关注点业绩披露要点：凯莱英2026年一季度主营收入18.02亿元，同比上升16.91%。业绩披露要点凯莱英2026年一季报显示，一季度公司主营收入18.02亿元，同比上升16.91%；归母净利润3.04亿元，同比下降6.82%；扣非净利润2.72亿元，同比下降10.88%；负债率13.25%，投资收益2477.27万元，财务费用7814.91万元，毛利率43.02%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050300000184.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["06821","002821"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1781752106562,"stockEarnings":[{"period":"1week","weight":0.0141},{"period":"1month","weight":-0.0317},{"period":"3month","weight":0.1972},{"period":"6month","weight":0.2132},{"period":"1year","weight":0.3483},{"period":"ytd","weight":0.2375}],"compareEarnings":[{"period":"1week","weight":0.0288},{"period":"1month","weight":-0.0057},{"period":"3month","weight":0.0253},{"period":"6month","weight":0.0559},{"period":"1year","weight":0.2128},{"period":"ytd","weight":0.0351}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"凯莱英医药集团(天津)股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"0人","perCapita":"--","listingDate":"2016-11-18","address":"天津市滨海新区经济技术开发区洞庭三街6号","registeredCapital":"36078万元","survey":" 凯莱英医药集团(天津)股份有限公司的主营业务是为国内外制药公司、生物技术公司提供药品全生命周期的一站式服务。公司的主要产品是小分子CDMO解决方案、新兴业务。凯莱英生物AsymBio偶联药物开发平台成功入围第12届WorldADCAwards“BestADCPlatformTechnology”奖项，印证了凯莱英生物在全球抗体偶联药物CDMO领域的卓越地位。","listedPrice":30.53},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"凯莱英(002821)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供凯莱英(002821)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"凯莱英,002821,凯莱英股票,凯莱英股票老虎,凯莱英股票老虎国际,凯莱英行情,凯莱英股票行情,凯莱英股价,凯莱英股市,凯莱英股票价格,凯莱英股票交易,凯莱英股票购买,凯莱英股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"凯莱英(002821)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供凯莱英(002821)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}